Merus und Caris Life Sciences geben Zusammenarbeit beim Nachweis von NRG1-Fusionen bei Krebspatienten bekannt

NEXT STORY
Kessler Topaz Meltzer & Check, LLP Reminds Chembio Diagnostics, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit
PREV STORY
Adaptive Biotechnologies Announces Proposed Public Offering of Common Stock
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours

PRESS RELEASE Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid ...

author_avatar
NASDAQ Market News

ONC Health IT Certification Program Director Joins EHNAC as Ex Officio Commissioner

FARMINGTON, Conn., Nov. 29, 2017 (GLOBE NEWSWIRE) -- The Electronic Healthcare Network Accreditation Commission ...

author_avatar
NASDAQ Market News

SCA Announces Inaugural Physician Advisory Board

DEERFIELD, Ill., June 15, 2016 (GLOBE NEWSWIRE) -- Surgical Care Affiliates, Inc. (NASDAQ:SCAI) ("SCA") ...

author_avatar
NASDAQ Market News